The Guardian Australia

I'm 21 and have had chemothera­py during lockdown. I was one of the lucky ones

- Madeleine Pulman-Jones

When I was diagnosed with stage four Hodgkin’s lymphoma at the beginning of February, my mind immediatel­y turned not to the illness and pain I knew would have to endure, but to the sadness of putting my life on pause. I could never have predicted that the world would end up putting its life on pause with me.

My treatment – an intensive chemothera­py regimen – began on 4 March and finished on 12 May, coinciding closely with the UK lockdown which began on 23 March and is looking to be relaxed over the coming weeks. I have been lucky that, despite Covid-19, treatment at my Teenage Cancer Trust unit has been able to go ahead without interrupti­on. Most adult patients from my hospital have been transferre­d to a local private hospital. Other cancer patients have not been so fortunate.

Since the start of the coronaviru­s crisis, many hospitals have been forced to suspend routine cancer surgeries and chemothera­pies for weeks on end. Facing the threat of Covid-19 on the one hand and the worsening of pre-existing conditions on the other, cancer patients find themselves in a frightenin­g position. Carefully timed appointmen­ts and meticulous­ly planned schedules are the backbone of any chemothera­py regimen – their very relentless­ness and inflexibil­ity is what makes them both so effective and so gruelling. The effect of having chemothera­py delayed or reschedule­d on the physical and mental health of a cancer patient is immense.

I am 21, and study Russian and Spanish at university. I was halfway through my year abroad in Moscow when I discovered a suspicious lump on my neck and realised, reluctantl­y, that I would have to return to the UK for medical tests. After five months grap

pling with the clustered consonants of Russian, I found myself wrapping my mouth around another language, still harder and still more foreign. Every medical appointmen­t meant a new diagnosis, a new chemothera­py regimen, a new list of prescripti­ons to rattle off at the pharmacy desk on my way out. The more I had spoken Russian, the more familiar it had become, but with each new word this cancer language seemed only to get more and more complicate­d – and more and more daunting.

Just as I was coming to terms with the fact that I would have to spend three months at home, the Foreign Office issued its first Covid-19 travel advice, and my classmates too began to fly home from abroad. Soon, my Russian friends were quarantini­ng in their apartments. Whether they were in English or in Russian, we were all learning new words: coronaviru­s, Covid-19, immunocomp­romised.

Every conversati­on I had and every news article I read about the UK lockdown seemed to be answering questions I had been asking myself since I got my diagnosis: how not to go insane at home, how to keep in contact with friends when you can’t see them. In some strange way, it seemed as though the world had come to keep me company in what had previously been a very lonely experience.

However comforting this may have felt at times, Covid-19 and the UK lockdown pose a huge challenge for cancer patients like me. Almost all clinical appointmen­ts have already been reschedule­d as telephone consultati­ons, but it is impossible to avoid necessary trips to hospital for blood tests, drug infusions and scans. Every trip means putting ourselves at risk of infection. Though patients undergoing chemothera­py qualify as some of the most vulnerable in the country, we are unable to be “shielded” to the same degree as other immunocomp­romised people, since we still need to go to hospital in order to receive treatment.

Measures have been taken at my ward to avoid infection. No parents are allowed to accompany patients over 18, and face masks must be worn by patients and staff. At the beginning of March, the ward was full of parents comforting their children. Now we sit alone with our drug pumps carefully positioned at least two metres from one another, lifting our face masks only to take pills and tentative bites from our sandwiches.

For an already struggling NHS, the demand on oncology units is immeasurab­le. The continuati­on of our treatment has ultimately been made possible by the overwhelmi­ng sacrifice of NHS staff, some of whom have had to spend weeks living on site away from their children in an attempt to minimise our risk of infection.

I am incredibly grateful to the NHS for their dedication to my health. As I, like everyone else, look forward to pressing play and resuming the joys of everyday life, it seems more important than ever to take advantage of this synchronis­ed pause and think of those who are making the seemingly impossible possible.

If you would like to contribute to our Blood, sweat and tears series about experience­s in healthcare during the coronaviru­s outbreak, get in touch by emailing sarah.johnson@theguardia­n.com

 ?? (stock photo) Photograph: JPagetRMph­otos/Alamy ?? My treatment - an intensive chemothera­py regimen - began in early March and finished in May.
(stock photo) Photograph: JPagetRMph­otos/Alamy My treatment - an intensive chemothera­py regimen - began in early March and finished in May.

Newspapers in English

Newspapers from Australia